Delayed 2nd dose was a good idea-squashed too quickly. Historic crisis demanded less rigidity. Just latest example.
Imagine another 50M with 1-dose right now...
Grateful to those who floated this early: @VirusesImmunity @zeynep @michaelmina_lab @ashishkjha @Bob_Wachter
-
-
Finally, the trial we suggested wasn't without some tiers: the elderly show the most need for boosters in earlier phase trials, and a trial delay more among younger cohorts (while carefully watching for negative signals) would have been one potential path.
-
*Federal allocations to long-term care facilities is a different question. There has been a real lag their due to the unexpectedly high refusal rates among the staff. Some states have relocated those.
End of conversation
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.